The Earliest Stage of Lung Adenocarcinoma: 
the Pathological Diagnosis and Clinical Significance of Adenocarcinoma In Situ

The Earliest Stage of Lung Adenocarcinoma: 
the Pathological Diagnosis and Clinical Significance of Adenocarcinoma In Situ

The International Agency for Research on Cancer (IARC) published the World Health Organization (WHO) classification of thoracic tumors (5th edition) in May 2021, only six years after the 4th edition of WHO Classification. With the application of low-dose spiral computed tomography (CT) as an early s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Huikang XIE, Gang CHEN
Formato: article
Lenguaje:ZH
Publicado: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2021
Materias:
adenocarcinoma in situ
world health organization
classification
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/5449f83c421d4ee49559d090cff2da56
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5449f83c421d4ee49559d090cff2da56
record_format dspace
spelling oai:doaj.org-article:5449f83c421d4ee49559d090cff2da562021-11-19T06:49:15ZThe Earliest Stage of Lung Adenocarcinoma: 
the Pathological Diagnosis and Clinical Significance of Adenocarcinoma In Situ1009-34191999-618710.3779/j.issn.1009-3419.2021.102.35https://doaj.org/article/5449f83c421d4ee49559d090cff2da562021-11-01T00:00:00Zhttp://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.35https://doaj.org/toc/1009-3419https://doaj.org/toc/1999-6187The International Agency for Research on Cancer (IARC) published the World Health Organization (WHO) classification of thoracic tumors (5th edition) in May 2021, only six years after the 4th edition of WHO Classification. With the application of low-dose spiral computed tomography (CT) as an early screening method for lung tumors in recent years, lung adenocarcinoma has become the main type of disease in many hospital surgical treatments. The WHO classification serves as the authoritative guide for pathological diagnosis, and any slight change in the classification is at the heart of pathologists, clinicians and patients. Adenocarcinoma in situ is a newly added type of adenocarcinoma diagnosis in the 4th edition of the WHO classification, and it is also the focus of clinical treatment and research at home and abroad in recent years. Because its catalog position has been adjusted in the 5th edition of the WHO classification, there has been a huge controversy and discussion among clinicians and patients that "adenocarcinoma in situ was excluded from the category of malignant tumors". This article will briefly explain the origin of the diagnosis of lung adenocarcinoma in situ, the adjustment of the new classification catalog, and whether adenocarcinoma in situ is benign or malignant.Huikang XIEGang CHENChinese Anti-Cancer Association; Chinese Antituberculosis Associationarticleadenocarcinoma in situworld health organizationclassificationNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ZHChinese Journal of Lung Cancer, Vol 24, Iss 11, Pp 753-755 (2021)
institution DOAJ
collection DOAJ
language ZH
topic adenocarcinoma in situ
world health organization
classification
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle adenocarcinoma in situ
world health organization
classification
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Huikang XIE
Gang CHEN
The Earliest Stage of Lung Adenocarcinoma: 
the Pathological Diagnosis and Clinical Significance of Adenocarcinoma In Situ
description The International Agency for Research on Cancer (IARC) published the World Health Organization (WHO) classification of thoracic tumors (5th edition) in May 2021, only six years after the 4th edition of WHO Classification. With the application of low-dose spiral computed tomography (CT) as an early screening method for lung tumors in recent years, lung adenocarcinoma has become the main type of disease in many hospital surgical treatments. The WHO classification serves as the authoritative guide for pathological diagnosis, and any slight change in the classification is at the heart of pathologists, clinicians and patients. Adenocarcinoma in situ is a newly added type of adenocarcinoma diagnosis in the 4th edition of the WHO classification, and it is also the focus of clinical treatment and research at home and abroad in recent years. Because its catalog position has been adjusted in the 5th edition of the WHO classification, there has been a huge controversy and discussion among clinicians and patients that "adenocarcinoma in situ was excluded from the category of malignant tumors". This article will briefly explain the origin of the diagnosis of lung adenocarcinoma in situ, the adjustment of the new classification catalog, and whether adenocarcinoma in situ is benign or malignant.
format article
author Huikang XIE
Gang CHEN
author_facet Huikang XIE
Gang CHEN
author_sort Huikang XIE
title The Earliest Stage of Lung Adenocarcinoma: 
the Pathological Diagnosis and Clinical Significance of Adenocarcinoma In Situ
title_short The Earliest Stage of Lung Adenocarcinoma: 
the Pathological Diagnosis and Clinical Significance of Adenocarcinoma In Situ
title_full The Earliest Stage of Lung Adenocarcinoma: 
the Pathological Diagnosis and Clinical Significance of Adenocarcinoma In Situ
title_fullStr The Earliest Stage of Lung Adenocarcinoma: 
the Pathological Diagnosis and Clinical Significance of Adenocarcinoma In Situ
title_full_unstemmed The Earliest Stage of Lung Adenocarcinoma: 
the Pathological Diagnosis and Clinical Significance of Adenocarcinoma In Situ
title_sort earliest stage of lung adenocarcinoma: 
the pathological diagnosis and clinical significance of adenocarcinoma in situ
publisher Chinese Anti-Cancer Association; Chinese Antituberculosis Association
publishDate 2021
url https://doaj.org/article/5449f83c421d4ee49559d090cff2da56
work_keys_str_mv AT huikangxie theearlieststageoflungadenocarcinomathepathologicaldiagnosisandclinicalsignificanceofadenocarcinomainsitu
AT gangchen theearlieststageoflungadenocarcinomathepathologicaldiagnosisandclinicalsignificanceofadenocarcinomainsitu
AT huikangxie earlieststageoflungadenocarcinomathepathologicaldiagnosisandclinicalsignificanceofadenocarcinomainsitu
AT gangchen earlieststageoflungadenocarcinomathepathologicaldiagnosisandclinicalsignificanceofadenocarcinomainsitu
_version_ 1718420310403842048

Ejemplares similares